Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Shares of Kaleido Biosciences are plunging after the company announced its intentions to cease all company operations, lay off its remaining staff and delist from the Nasdaq Exchange.
Zacks Investment Research lowered shares of Kaleido Biosciences (NASDAQ:KLDO – Get Rating) from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Kaleido Biosciences Inc. is a clinical-stage healthcare company. It focuses on leveraging the potential of the microbiome organ to treat disease and improve human […]
Kaleido Biosciences (NASDAQ:KLDO) Upgraded to Buy at Zacks Investment Research etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Kaleido Biosciences (NASDAQ:KLDO) Rating Lowered to Hold at Zacks Investment Research etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.